Retrospective clinical study on the comprehensive treatment of retinoblastoma
10.3760/cma.j.cn511434-20200205-00040
- VernacularTitle:视网膜母细胞瘤综合治疗的回顾性临床研究
- Author:
Yong CHENG
1
;
Zhongxu JIA
;
Mingwei ZHAO
;
Jianhong LIANG
Author Information
1. 北京大学人民医院眼科、眼视光中心 眼病与视光医学研究所 视网膜脉络膜诊治研究北京市重点实验室 北京大学医学部眼视光学院 100044
- From:
Chinese Journal of Ocular Fundus Diseases
2020;36(6):419-424
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To observe the curative effect, survival rate, enucleation rate and pathological characteristics of retinoblastoma (RB) in children.Methods:Retrospective clinical study. From March 1999 to December 2018, a total of 313 patients (445 eyes) with RB diagnosed in Ophthalmology Department of Peking University People’s Hospital were enrolled in the study. Among them, 175 were male (55.9%), 138 were female (44.1%); 181 were monocular and 132 were binocular. The international standard of intraocular RB staging (IIRC) was 6, 13, 6, 52, 227 and 9 patients of A, B, C, D, E and extraocular stages respectively. Among the 313 patients, 245 patients were confirmed to the survivance, of which 22 cases (9.0%, 22/245) died. Among 445 eyes, 330 eyes definitely whether or not were enucleated; 184 eyes had definite IIRC stage, eye examination results, definite treatment plan and times before enucleation and definite pathological tumor node metastasis stage after operation. The basic information, demographic characteristics, clinical information, enucleation and treatment plan, pathological and immunohistochemical results were recorded. Binary logistic regression was used to analyze the risk factors of high risk pathological features (HRF) and prognosis in patients with RB.Results:From 1999 to 2018, the survival rate of 245 patients was increased from 82.6% to 96.3% year by year; the enucleation rate of 330 eyes with final enucleation was reduced from68.8% to 58.3% year by year. The rate of enucleation in stage D and stage E decreased from 83.3% and 100% before 2005 to 37.5% and 85.4% after 2014, respectively. Monocular disease ( β=-1.551, P=0.005), stage D, stage E and extraocular stage in IIRC stage ( P<0.005) were the independent risk factors of RB enucleation, while the protective factors were Interventional chemotherapy of ophthalmic artery (IAC) ( β=-0.877, P<0.001). HRF was found in 51 eyes (27.7%). Age of onset ( β=0.019, P=0.016) and glaucoma ( β=0.816, P=0.050) were independent risk factors for HRF in RB pathology, while IAC treatment was the protective factor for enucleation ( β=21.432, P<0.001). Conclusions:After comprehensive treatment, the general trend of RB enucleation rate is gradually decreasing. IAC treatment can reduce the enucleation rate of stage D and E. The older age of onset and glaucoma stage are the independent risk factors of HRF, and IAC can reduce the risk factors of HRF.
